NCT06827054View on ClinicalTrials.gov

Psilocybin With Psychotherapy for Improving Chronic Pain in Cancer Patients Requiring Opioids

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

November 15, 2025

Primary Completion Date

May 5, 2026

Study Completion Date

May 5, 2027

Conditions
Hematopoietic and Lymphatic System NeoplasmMalignant Solid Neoplasm
Interventions
PROCEDURE

Biospecimen Collection

Undergo collection of blood and urine samples

PROCEDURE

Functional Magnetic Resonance Imaging

Undergo fMRI

OTHER

Interview

Ancillary studies

DRUG

Psilocybine

Given PO

BEHAVIORAL

Psychotherapy

Attend psychotherapy sessions

OTHER

Questionnaire Administration

Ancillary studies

Trial Locations (1)

14263

Roswell Park Cancer Institute, Buffalo

All Listed Sponsors
lead

Roswell Park Cancer Institute

OTHER